Bild 1 von 9
Galerie
Bild 1 von 9
NEU Krebs-Pharmakologie Ein illustriertes Handbuch von Krebs-Medikamenten von Judith Karp-
US $60,00
Ca.EUR 51,13
oder Preisvorschlag
Artikelzustand:
Neu
Neues, ungelesenes, ungebrauchtes Buch in makellosem Zustand ohne fehlende oder beschädigte Seiten. Genauere Einzelheiten entnehmen Sie bitte dem Angebot des Verkäufers.
2 verfügbar
- Sofort-KaufenNEU Krebs-Pharmakologie Ein illustriertes Handbuch von Krebs-Medikamenten von Judith Karp
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Versand:
US $5,67 (ca. EUR 4,83) USPS Media MailTM.
Standort: Hagerstown, Maryland, USA
Lieferung:
Lieferung zwischen Mo, 6. Okt und Di, 14. Okt nach 94104 bei heutigem Zahlungseingang
Rücknahme:
Keine Rücknahme.
Zahlungen:
Sicher einkaufen
- Gratis Rückversand im Inland
- Punkte für jeden Kauf und Verkauf
- Exklusive Plus-Deals
Der Verkäufer ist für dieses Angebot verantwortlich.
eBay-Artikelnr.:376476688275
Artikelmerkmale
- Artikelzustand
- ISBN
- 9780826149329
Über dieses Produkt
Product Identifiers
Publisher
Springer Publishing Company, Incorporated
ISBN-10
0826149324
ISBN-13
9780826149329
eBay Product ID (ePID)
4059330318
Product Key Features
Number of Pages
454 Pages
Language
English
Publication Name
Cancer Pharmacology : an Illustrated Manual of Anticancer Drugs
Publication Year
2023
Subject
Chemotherapy, Hematology, Pharmacy, Internal Medicine, Oncology
Features
New Edition
Type
Textbook
Subject Area
Medical
Format
Trade Paperback
Dimensions
Item Weight
28.9 Oz
Item Length
10 in
Item Width
7 in
Additional Product Features
Edition Number
2
Intended Audience
Scholarly & Professional
LCCN
2023-005637
Dewey Edition
23
Illustrated
Yes
Dewey Decimal
615.798
Table Of Content
List of Contributors Preface PART 1. BASIC PRINCIPLES OF CANCER PHARMACOLOGY AND CLINICAL DRUG DEVELOPMENT Chapter 1. Drug Development in Oncology 101 by Edward A. Sausville, MD, PhD and Ashkan Emadi, MD, PhD Chapter 2. Pharmacogenomics by Molly Graveno, PharmD, BCOP Chapter 3. Critical Components of Clinical Trials Development: From Bench to Bedside and Back by S. Percy Ivy, MD, Richard F. Little, MD, and Joshua F. Zeidner, MD Chapter 4. Drug Development and Regulatory Considerations by Vicky Hsu, PhD, Matthew D. Thompson, PhD, MPH, Donna Przepiorka, MD, PhD, and Olanrewaju O. Okusanya, Pharm.D., MS PART 2. CLASSICAL CYTOTOXIC AGENTS Chapter 5. Alkylating Agents and Drugs Perturbing DNA Structure by Ashkan Emadi, MD, PhD and Edward A. Sausville, MD, PhD Chapter 6. Pyrimidine- and Purine-based Antimetabolites, Hydroxyurea, Asparaginases by Ashkan Emadi, MD, PhD and Judith E. Karp, MD Chapter 7. Antifolate Antimetabolites by Justin Lawson, PharmD, BCOP Chapter 8. Antimitotics by Edward A. Sausville, MD, PhD and Ashkan Emadi, MD, PhD PART 3. EXPLOITING CELLULAR AND EXTRACELLULAR PATHWAYS Chapter 9. Drugs Targeting DNA Repair, Cell Cycle and Apoptosis by Mira A. Kohorst, MD and Scott H. Kaufmann, MD, PhD Chapter 10. Epigenetic Modulators by Sergiu Pasca, MD and Lukasz P. Gondek, MD, PhD Chapter 11. Differentiating Agents and Microenvironment by Yuya Nagai, MD, PhD and Gabriel Ghiaur, MD, PhD PART 4. ORGAN-TARGETED APPROACHES Chapter 12. Targeted Therapeutics (Small Molecules) by Yuchen (Jake) Liu, MD and Ashkan Emadi, MD, PhD Chapter 13. Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer by Amy M. Fulton, PhD and Katherine H. R. Tkaczuk, MD Chapter 14. Androgen Receptor Axis Targeting in the Treatment of Prostate Cancer by Vincent C. O. Njar, PhD, and Arif Hussain, MD Chapter 15. Multiple Myeloma as a Paradigm for Multi-Targeted Intervention by Kathryn Maples, PharmD, BCOP and Sagar Lonial, MD PART 5. IMMUNE-TARGETED STRATEGIES Chapter 16. Transplant-Related Agents: Focus on Graft vs. Host Disease Prevention and Treatment by Vedran Radojcic, MD Chapter 17. Monoclonal Antibodies Including Immunoconjugates, Antibody-Drug Conjugates, Immunoconjugates, and Cytokine-Directed Agents by Alison Duffy, PharmD, BCOP and Ciera Bernhardi, PharmD, BCOP Chapter 18. Immunotherapeutics: Immune Checkpoint Inhibitors, Vaccines, Bispecifics, and Engineered T Cells by Mark Yarchoan, MD and Elizabeth Jaffee, MD Index
Edition Description
New Edition
Synopsis
Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs, Second Edition is a visually engaging reference detailing the essential basic and clinical science of all approved, effective, and life-prolonging drug therapies in oncology. Now with a greater emphasis on clinical context, application, and management in each chapter, this significantly revised edition provides both early-career and seasoned clinicians with a practical, bench-to-bedside approach and patient-oriented guide. The book provides detailed coverage of the major advances in cancer pharmacology at the forefront of our standards of care for solid tumors and hematologic malignancies, in addition to the basic science that is directly necessary and applicable when at the patient's bedside. Everything from traditional cytotoxic agents to targeted genomic, epigenomic, hormonal, and immunotherapeutic agents is explored, in addition to a new chapter covering pharmacogenomics. Accompanied by elegant illustrations, each chapter details the tumor microenvironment, chemical structures of agents, pharmacodynamics, pharmacokinetics, pharmacogenomic and molecular properties of the various agents, and their mechanisms of action. The book covers alkylating agents, antimetabolites, antimitotics, epigenetic modulators, hormonal agents, targeted therapies, monoclonal antibodies, immunotherapeutic agents, and much more. Thoroughly updated to include new FDA-approved treatments and applications, and written by leading experts in cancer pharmacology, this second edition continues to be a "must have" for anyone involved in the basic, translational, or clinical aspects of oncology and hematology, including clinicians, pharmacists, nurses, and trainees. Key Features: Over 150 beautiful illustrations depict structures, pharmacokinetics, pharmacodynamics, and pharmacogenomics associated with each class of agents Contains more than 160 high-yield hematology and oncology board-style chapter review questions (more than double the previous edition) with descriptive rationales Describes how chemotherapy, targeted therapy, immunotherapy, and hormonal therapy work, and why they are expected to work adjuvantly, neoadjuvantly, and in combination with other treatment modalities Thoroughly updated and revised chapters cover all new FDA drug approvals, disease-site indications, clinical applications and management of drug-to-drug interactions, and toxicities Discusses challenges related to drug development, drug approval, and regulatory issues in relation to anticancer treatments Provides important pharmacotherapy context with clinical pearls in each chapter that help support a patient-oriented, bedside approach Purchase includes access to the ebook for use on most mobile devices or computers, A visually engaging reference detailing the essential basic and clinical science of all approved, effective, and life-prolonging drug therapies in oncology. Now with a greater emphasis on clinical context, application, and management, this significantly revised edition provides a practical, bench-to-bedside approach and patient-oriented guide., Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs, Second Edition is a visually engaging reference detailing the essential basic and clinical science of all approved, effective, and life-prolonging drug therapies in oncology. Now with a greater emphasis on clinical context, application, and management in each chapter, this significantly revised edition provides both early-career and seasoned clinicians with a practical, bench-to-bedside approach and patient-oriented guide. The book provides detailed coverage of the major advances in cancer pharmacology at the forefront of our standards of care for solid tumors and hematologic malignancies, in addition to the basic science that is directly necessary and applicable when at the patient's bedside. Everything from traditional cytotoxic agents to targeted genomic, epigenomic, hormonal, and immunotherapeutic agents is explored, in addition to a new chapter covering pharmacogenomics. Accompanied by elegant illustrations, each chapter details the tumor microenvironment, chemical structures of agents, pharmacodynamics, pharmacokinetics, pharmacogenomic and molecular properties of the various agents, and their mechanisms of action. The book covers alkylating agents, antimetabolites, antimitotics, epigenetic modulators, hormonal agents, targeted therapies, monoclonal antibodies, immunotherapeutic agents, and much more. Thoroughly updated to include new FDA-approved treatments and applications, and written by leading experts in cancer pharmacology, this second edition continues to be a "must have" for anyone involved in the basic, translational, or clinical aspects of oncology and hematology, including clinicians, pharmacists, nurses, and trainees. Key Features: Over 150 beautiful illustrations depict structures, pharmacokinetics, pharmacodynamics, and pharmacogenomics associated with each class of agents Contains more than 160 high-yield hematology and oncology board-style chapter review questions (more than double the previous edition) with descriptive rationales Describes how chemotherapy, targeted therapy, immunotherapy, and hormonal therapy work, and why they are expected to work adjuvantly, neoadjuvantly, and in combination with other treatment modalities Thoroughly updated and revised chapters cover new FDA drug approvals, disease-site indications, clinical applications and management of drug-to-drug interactions, and toxicities Discusses challenges related to drug development, drug approval, and regulatory issues in relation to anticancer treatments Provides important pharmacotherapy context with clinical pearls in each chapter that help support a patient-oriented, bedside approach
LC Classification Number
RC271.C5
Artikelbeschreibung des Verkäufers
Rechtliche Informationen des Verkäufers
Info zu diesem Verkäufer
The Overwatch Continued
100% positive Bewertungen•1.952 Artikel verkauft
Angemeldet als gewerblicher Verkäufer
Verkäuferbewertungen (723)
- t***a (4842)- Bewertung vom Käufer.Letzte 6 MonateBestätigter KaufQUICK SHIPPING…EXCELLENT COMMUNICATION…WELL PACKAGED!! GREAT JERSEY AS DESCRIBED! THANK YOU!!!
- o***n (48)- Bewertung vom Käufer.Letzter MonatBestätigter KaufArrived on time and exactly as described! Great value and in new/perfect condition. I appreciate the lengths the shipper went in packaging to ensure it arrived safely
- r***e (13)- Bewertung vom Käufer.Letzte 6 MonateBestätigter KaufShipping was fast very well packaged, was exactly as described, great value.BLENKO - Handcrafted - Yellow/Green Ruffle Art Swirl Glass Bowl - Bottom Chip (Nr. 376211617350)
Noch mehr entdecken:
- Pharmakologie Studium und Erwachsenenbildung,
- Deutsche Studium und Erwachsenenbildung Pharmakologie,
- Pharmakologie Studium und Erwachsenenbildung als gebundene Ausgabe,
- Pharmakologie Studium und Erwachsenenbildung Ab 2010,
- Pharmakologie Studium und Erwachsenenbildung im Taschenbuch-Format,
- Illustrierte Belletristik-Bücher,
- Illustrierte Sachbuch Bücher,
- Illustrierte Belletristik Bücher Abenteuer,
- Illustrierte Bücher mit Kinder- & Jugendliteratur,
- Illustrierte Sachbuch Erwachsene Bücher
The Overwatch Continued
100% positive Bewertungen•1.952 Artikel verkauft
Angemeldet als gewerblicher Verkäufer
Verkäuferbewertungen (723)
- t***a (4842)- Bewertung vom Käufer.Letzte 6 MonateBestätigter KaufQUICK SHIPPING…EXCELLENT COMMUNICATION…WELL PACKAGED!! GREAT JERSEY AS DESCRIBED! THANK YOU!!!
- o***n (48)- Bewertung vom Käufer.Letzter MonatBestätigter KaufArrived on time and exactly as described! Great value and in new/perfect condition. I appreciate the lengths the shipper went in packaging to ensure it arrived safely
- r***e (13)- Bewertung vom Käufer.Letzte 6 MonateBestätigter KaufShipping was fast very well packaged, was exactly as described, great value.BLENKO - Handcrafted - Yellow/Green Ruffle Art Swirl Glass Bowl - Bottom Chip (Nr. 376211617350)